Testing a dye to better see lung nodules during bronchoscopy
Part of Cancer, Lungs & breathing clinical trials.
This trial tests whether a special dye attached to a cancer-targeting drug can help doctors see lung nodules more clearly during a bronchoscopy. This may make it easier to find and diagnose cancer during the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have at least one lung nodule or mass that is suspected to be cancer.
- You are healthy enough to undergo a bronchoscopy to get a tissue sample.
- You have never had an allergic reaction to the drug bevacizumab (Avastin).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study uses special drug dyes (bevacizumab and cetuximab, each tagged for imaging) during an esophagus scope to help doctors find very early abnormal cells, like low- or high-grade pre-cancer and superficial cancer. If you qualify, the goal is earlier detection and better targeting during diagnosis and treatment.
This trial tests a new targeted therapy (DZD9008) combined with a drug that blocks blood vessel growth (bevacizumab) for people with a specific type of advanced lung cancer (EGFR mutation). The goal is to see if this combination works better than current treatments.
This trial tests whether a special dye can make cancer cells glow during a bronchoscopy, helping doctors see and biopsy tumors more precisely. It is for people with stage III lung cancer that cannot be removed by surgery and who have already completed chemoradiotherapy.
This trial compares a combination of anti-angiogenics (bevacizumab) plus chemotherapy (paclitaxel and carboplatin) against Avastin-based treatment in people with advanced non-small cell lung cancer. It aims to find out whether the study treatment is safer and works better for shrinking tumors and improving outcomes.
This trial tests a new way to find and remove small lung nodules using a robot-guided camera to mark the nodule with dye, then a video-assisted surgery to remove it. It may help patients whose nodules are hard to locate during surgery.
This study looks for blood test markers that may predict who survives at 6 months after starting bevacizumab for glioblastoma that has come back. It does not aim to cure the cancer by itself, but to improve doctors’ ability to choose the most helpful treatment plan.
Hear when a new Lung Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.